CRDF Cardiff Oncology
- 4.090
- -0.270-6.19%
Cardiff Oncology News
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Levine James E.
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kabbinavar Fairooz
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Erlander Mark
Cardiff Oncology | 8-K: Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Cardiff Oncology | 10-K: Annual report
Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Acorn Bioventures, L.P.(4.20%),Acorn Capital Advisors GP, LLC(4.20%), etc.
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Cardiff Oncology | 8-K: Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
Cardiff Oncology | 10-Q: Q3 2023 Earnings Report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
Cardiff Oncology | 10-Q: Q2 2023 Earnings Report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Cardiff Oncology | 8-K: Current report
Analysis
Price Target
No Data
